Imugene’s $20 million boost and cancer trial updates

(7:42)

Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success

(16:2)

Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US

(5:25)

Imugene Science Series With Dr Yuman Fong - November 2024

(20:20)

Imugene MAST trial delivers two-year complete response in bile tract cancer patient

(4:54)

Meet Garrett Gincley, Vice President of Cell Therapy, External Manufacturing, and Imugene Quality.

(56)

Meet Tilanthi Jayawardena, Imugene’s Translational Sciences Lead for azer-cel.

(51)

Investor webinar: Azer-cel trial update, September 2024

(25:35)

Imugene reports promising results in Phase 1b trial for azer-cel in DLBCL

(4:54)

CEO Leslie Chong And COO Dr Bradley Glover Speak With JustStocks Video

(7:17)

Imugene’s $20 million boost and cancer trial updates

(7:42)

Imugene (ASX:IMU) | JMM \u0026 éthica Capital Innovation Interview \\ May 2024

(5:4)

Imugene Limited (ASX:IMU) Three Complete Responses in Azer-Cel Phase 1b Trial

(3:51)

Imugene Science Series With Dr Yuman Fong - November 2024

(20:20)

Imugene MAST trial delivers two-year complete response in bile tract cancer patient

(4:54)

Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US

(5:25)

Meet Garrett Gincley, Vice President of Cell Therapy, External Manufacturing, and Imugene Quality.

(56)

7 News Australia | Australian company Imugene; saving lives using a cancer eating virus

(2:18)

Imugene begins VAXINIA trial for bile tract cancer

(10:)

Imugene @ AACR 2020: PD1-Vaxx (IMU-201) Phase 1 Briefing

(6:12)

Imugene PD1 Vaxx 1080p

(4:27)

Meet Tilanthi Jayawardena, Imugene’s Translational Sciences Lead for azer-cel.

(51)

Imugene Limited (ASX: IMU) Emergence 2024: Presentation by Leslie Chong, Managing Director and CEO

(7:40)

Imugene CEO And COO Speak With JustStocks Video After Promising Results In Blood Cancer Trial

(7:17)

Imugene's new cancer therapy CD19 (OnCARlytics) considered the 'Holy Grail'

(6:16)

Just the Facts: Imugene receives Orphan Drug Designation for VAXINIA from FDA

(1:58)

Imugene featured on Behind The Scenes with Host Laurence Fishburne.

(5:15)

Imugene (ASX:IMU) | Webinar with Leslie Chong | 07/11/24

(26:56)

Imugene: A worldwide license to attack blood cancer

(2:59)